What are the recommended treatments, including non‑pharmacologic measures and safe medications, for nausea (morning sickness) in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Nausea in Pregnancy

Start with dietary modifications and vitamin B6 (10-25 mg every 8 hours), then escalate to doxylamine-pyridoxine combination if symptoms persist, followed by metoclopramide for refractory cases, reserving ondansetron for severe symptoms after 10 weeks gestation. 1, 2, 3, 4

Initial Non-Pharmacologic Management

Early intervention is critical because it may prevent progression to hyperemesis gravidarum, which affects 0.3-2% of pregnancies and can lead to hospitalization. 1, 3 The PUQE (Pregnancy-Unique Quantification of Emesis) score should be used to assess severity: mild (≤6), moderate (7-12), or severe (≥13). 2, 3

Dietary and lifestyle modifications include:

  • Small, frequent meals (6-8 per day) rather than three large meals 3
  • BRAT diet (bananas, rice, applesauce, toast) for bland, easily digestible options 3
  • High-protein, low-fat meals to minimize gastric irritation 3
  • Avoid spicy, fatty, acidic, and fried foods 3
  • Identify and eliminate specific triggers like strong food odors 3

Stepwise Pharmacologic Treatment Algorithm

First-Line: Vitamin B6 and Doxylamine

Vitamin B6 (pyridoxine) 10-25 mg orally every 8 hours is the initial pharmacologic treatment, safe at doses up to 100 mg/day. 2, 3, 4 However, chronic doses exceeding 100 mg/day can cause peripheral neuropathy and should be avoided. 2

If vitamin B6 alone is insufficient, escalate to doxylamine-pyridoxine combination (Diclectin/Diclegis) 10 mg/10 mg delayed-release formulation, which is the only FDA-approved medication specifically for nausea and vomiting in pregnancy with a pregnancy safety rating of A. 2, 4, 5 The American College of Obstetricians and Gynecologists (ACOG) recommends this as preferred first-line pharmacologic therapy. 2

Ginger supplementation 250 mg capsules four times daily can be added as an adjunct safe option. 3

Second-Line: Metoclopramide

Metoclopramide 5-10 mg orally every 6-8 hours (3-4 times daily, not once daily) should be used when first-line therapy fails. 1, 2, 4 This is the preferred third-line agent based on the American Gastroenterological Association (AGA) recommendations. 2

A meta-analysis of 33,000 first-trimester exposures showed no significant increase in major congenital defects (odds ratio 1.14,99% CI 0.93-1.38). 2, 4 Metoclopramide has fewer side effects than promethazine, including less drowsiness, dizziness, and dystonia. 2, 4 ACOG advises withdrawing metoclopramide if extrapyramidal symptoms develop. 2

Third-Line: Antihistamines

Promethazine is a safe H1-receptor antagonist throughout pregnancy with extensive clinical experience, indicated when vitamin B6 and doxylamine are insufficient. 2 Other antihistamines like dimenhydrinate and meclizine are safe alternatives. 2

Fourth-Line: Ondansetron (Use with Caution)

Ondansetron 8 mg orally every 8-12 hours should be reserved for refractory cases, particularly after 10 weeks gestation. 2, 4 ACOG recommends case-by-case decision-making for use before 10 weeks due to small absolute risk increases: cleft palate increases from 11 to 14 per 10,000 births (0.03% absolute increase) and ventricular septal defects increase by 0.3% absolute. 2, 4

Despite these concerns, the European Society for Medical Oncology (ESMO) states ondansetron may be safely administered during the first trimester when benefits outweigh risks in severe cases. 2

Severe/Refractory Cases: IV Therapy and Corticosteroids

For patients requiring hospitalization with severe symptoms (PUQE ≥13), persistent vomiting despite oral antiemetics, dehydration, electrolyte abnormalities, or weight loss >5% of prepregnancy weight: 2

IV management includes:

  • Normal saline (0.9% NaCl) with potassium chloride guided by daily electrolyte monitoring 2
  • Thiamine 100 mg IV (as part of vitamin B complex) BEFORE any dextrose administration to prevent Wernicke encephalopathy, then 50 mg daily maintenance 1, 2, 4
  • IV metoclopramide 10 mg slowly over 1-2 minutes every 6-8 hours as preferred IV antiemetic 2
  • IV ondansetron 0.15 mg/kg per dose (maximum 16 mg) over 15 minutes if metoclopramide fails 2

Methylprednisolone 16 mg IV every 8 hours for up to 3 days, then taper over 2 weeks should be reserved as last resort for severe, refractory hyperemesis gravidarum only. 1, 2, 4 This should be avoided before 10 weeks gestation due to small risk of cleft palate, but at 20 weeks gestation the risk is substantially lower. 2, 4 Limit maximum duration to 6 weeks. 2

Critical Clinical Pearls

  • Early pharmacologic treatment prevents progression to severe disease—do not delay waiting for dietary modifications alone to work. 2, 3
  • Thiamine supplementation is essential in prolonged vomiting to prevent Wernicke encephalopathy. 1, 2, 4
  • Monitor for dehydration signs: orthostatic hypotension, decreased skin turgor, dry mucous membranes. 2
  • Check electrolytes, liver enzymes (elevated in 40-50% of hyperemesis cases), and thyroid function tests in severe cases. 2
  • Enteral or parenteral nutrition may be necessary if weight loss persists despite pharmacotherapy. 2

Common Pitfalls to Avoid

  • Do not dismiss nausea and vomiting as an inconsequential part of pregnancy—it has significant physical and psychological morbidity. 6
  • Do not delay treatment—progression to hyperemesis gravidarum becomes more difficult to control and may require hospitalization. 1, 7
  • Do not use ondansetron as first-line therapy before 10 weeks—metoclopramide has superior safety profile in early pregnancy. 2, 4
  • Do not give dextrose before thiamine—this can precipitate Wernicke encephalopathy. 2
  • Do not exceed 100 mg/day of vitamin B6 chronically—risk of peripheral neuropathy. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nausea Management in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Managing Nausea in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safe Nausea Medications for Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacologic management of nausea and vomiting of pregnancy.

The Journal of family practice, 2014

Research

Optimal management of nausea and vomiting of pregnancy.

International journal of women's health, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.